CVR number 41889128
Industry 46.4610 Wholesale of pharmaceutical goods

Selskabet af 21. juni 2023 ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2017
N/A
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 3.7% 7.3%  
Credit score (0-100)  0 0 0 52 32  
Credit rating  N/A N/A N/A BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
N/A
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 4,181 12,572  
EBITDA  0.0 0.0 0.0 3,052 5,989  
EBIT  0.0 0.0 0.0 3,052 5,900  
Pre-tax profit (PTP)  0.0 0.0 0.0 3,046.9 5,821.2  
Net earnings  0.0 0.0 0.0 2,368.2 4,524.1  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 3,047 5,816  
 
See the entire income statement

Balance sheet (kDKK) 
2017
N/A
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
Tangible assets total  0.0 0.0 0.0 0.0 426  
Shareholders equity total  0.0 0.0 0.0 2,408 582  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 0.0 0.0 4,708 3,226  
Net Debt  0.0 0.0 0.0 -2,396 -2,518  
 
See the entire balance sheet

Volume 
2017
N/A
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 4,181 12,572  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 200.7%  
Employees  0 0 0 2 14  
Employee growth %  0.0% 0.0% 0.0% 0.0% 600.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 4,708 3,226  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% -31.5%  
Added value  0.0 0.0 0.0 3,051.9 5,988.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 338  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 2.0  

Profitability 
2017
N/A
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 73.0% 46.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 64.8% 148.6%  
ROI %  0.0% 0.0% 0.0% 126.7% 508.1%  
ROE %  0.0% 0.0% 0.0% 98.3% 302.6%  

Solidity 
2017
N/A
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
Equity ratio %  0.0% 0.0% 0.0% 51.2% 14.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -78.5% -42.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2017
N/A
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
Quick Ratio  0.0 0.0 0.0 2.0 1.0  
Current Ratio  0.0 0.0 0.0 2.0 1.0  
Cash and cash equivalent  0.0 0.0 0.0 2,395.6 2,518.2  

Capital use efficiency 
2017
N/A
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 2,408.2 -116.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
N/A
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 1,526 428  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 1,526 428  
EBIT / employee  0 0 0 1,526 421  
Net earnings / employee  0 0 0 1,184 323